Top

Journal of Cancer Survivorship

Published in:

01-06-2015

Effects of web-based intervention on risk reduction behaviors in melanoma survivors

Authors: Deborah J. Bowen, Wylie Burke, Jennifer L. Hay, Hendrika Meischke, Julie N Harris

Published in: Journal of Cancer Survivorship | Issue 2/2015

Abstract

Purpose

Melanoma is the most severe form of skin cancer, and survivors of melanoma carry increased risk of additional melanoma diagnosis. Multiple methods exist for primary and secondary prevention of melanoma in survivors. This study tested a web-based family communication intervention to improve these preventive behaviors in melanoma families.

Methods

Families (a survivor, at least one first-degree relative and a parent) were randomized either to receive the intervention package or to serve as comparison families. We assessed melanoma prevention behaviors in each cohort member before and after the intervention. The intervention was a web-based multicomponent intervention focused on increasing family communication and exchange of risk information.

Results

Results indicated that, compared to comparison survivors, intervention survivors improved their skin self-examination and their sun protection behaviors significantly from before to after intervention.

Conclusion

These data support the use of web-based interventions for behavioral changes in survivors and allow for consideration of dissemination of this successful intervention. These data have implications for interventions that can help cancer families deal with issues of risk and illness.

Implications for cancer survivors

These data indicate that survivors can benefit from exposure to a website that helps direct their future health behaviors.

What are the key statistics about melanoma skin cancer? In: Melanoma Skin Cancer. American CancerSociety 2014; http://www.cancer.org/cancer/skincancer-melanoma/detailedguide/melanoma-skin-cancer-key-statistics.

SEER Cancer Statistics Review, 1975–2010, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2010/, based on November 2012 SEER data submission, posted to the SEER web site, April 2013. Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds).

ASCO 2011 Abstract: LBA5 Phase 3 randomized study of ipilimumab (IPI) plus dacarbazine (DTIC) vs DTIC alone as first line treatment in patients with unresectable stage III or IV melanoma. Wolchok JD, Thomas L, Bondarenko IN, O’Day S, Weber JS, Garbe C, Francis S, Ibrahim RA, Hoos A, Robert C.

Coyte A, Morrison DS, McLoone P. Second primary cancer risk—the impact of applying different definitions of multiple primaries: results from a retrospective population-based cancer registry study. BMC Cancer. 2014. doi:10.1186/1471-2407-14-272.PubMedCentralPubMed

Begg CB, Hummer A, Mujumdar U, Armstrong BK, Kricker A, Marrett LD, et al. Familial aggregation of melanoma risks in a large population-based sample of melanoma cases. Cancer Causes Control. 2004. doi:10.1007/s10552-004-2474-1.PubMed

Swetter SM, Pollitt RA, Johnson TM, Brooks DR, Geller AC. Behavioral determinants of successful early melanoma detection: role of self and physician skin examination. Cancer. 2012. doi:10.1002/cncr.26707.PubMedCentral

Bichakjian CK, Halpern AC, Johnson TM, Hood AF, Grichnik J, Swetter SM, et al. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol. 2011. doi:10.1016/j.jaad.2011.04.031.

Melanoma Skin Cancer. In Skin Cancer. American Cancer Society. 2013. http://www.cancer.org/acs/groups/cid/documents/webcontent/003120-pdf.pdf. Accessed 2 May 2014.

Chen ST, Geller AC, Tsao H. Update on the epidemiology of melanoma. Curr Dermatol Rep. 2013. doi:10.1007/s13671-012-0035-5.PubMedCentralPubMed

10.

Mujumdar UJ, Hay JL, Monroe-Hinds YC, Hummer AJ, Begg CB, Wilcox HB, et al. Sun protection and skin self-examination in melanoma survivors. Psycho-Oncology. 2009. doi:10.1002/pon.1510.PubMedCentralPubMed

11.

Manne S, Lessin S. Prevalence and correlates of sun protection and skin self-examination practices among cutaneous malignant melanoma survivors. J Behav Med. 2006. doi:10.1007/s10865-006-9064-5.PubMed

12.

Oliveria SA, Shuk E, Hay JL, Heneghan M, Goulart JM, Panageas K, et al. Melanoma survivors: health behaviors, surveillance, psychosocial factors, and family concerns. Psycho-Oncology. 2013. doi:10.1002/pon.2059.PubMed

13.

Körner A, Drapeau M, Thombs BD, Rosberger Z, Wang B, Khanna M, et al. Barriers and facilitators of adherence to medical advice on skin self-examination during melanoma follow-up care. BMC Dermatol. 2013. doi:10.1186/1471-5945-13-3.PubMedCentralPubMed

14.

Gritz ER, Tripp MK, Peterson SK, Prokhorov AV, Shete SS, Urbauer DL, Fellman BM, J Lee JE, Gershenwald JE. Randomized Controlled Trial of a Sun Protection Intervention for Children of Melanoma Survivors. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 2013; doi:10.1158/1055-9965.

15.

Geller AC, Emmons KE, Brooks DR, Powers C, Zhang Z, Koh HK, et al. A randomized trial to improve early detection and prevention practices among siblings of melanoma patients. Cancer. 2006. doi:10.1002/cncr.22050.

16.

Bowen DJ, Jabson JM, Haddock N, Hay J, Edwards K. Skin care behaviors among melanoma survivors. Psycho-Oncology. 2011. doi:10.1002/pon.2017.PubMed

17.

Pitceathly C, Maguire P. The psychological impact of cancer on patients’ partners and other key relatives. Eur J Cancer. 2003. doi:10.1016/S0959-8049(03)00309-5.PubMed

18.

Novilla MLB, Barnes MD, Natalie G, Williams PN, Rogers J. Public health perspectives on the family: an ecological approach to promoting health in the family and community. Family Commun Health. 2006;29(1):28–42.CrossRef

19.

Hay J, Shuk E, Brady MS, Berwick M, Ostroff J, Halpern A. Family communication after melanoma diagnosis. Arch Dermatol. 2008. doi:10.1001/archderm.144.4.553.PubMedCentral

20.

Geller 23296633 pulls up oliviera reference #13. The paper references #20 with respect to poor communication among family members about family risk.

21.

Cappelli M et al. Psychological and social predictors of decisions about genetic testing for breast cancer in high-risk women. Psychol, Health Med. 2001;6(3):321–33.CrossRef

22.

Friedman LC, Webb JA, Everett TE. Psychosocial and medical predictors of colorectal cancer screening among low-income medical outpatients. J Cancer Educ. 2004;19(3):180–6.CrossRefPubMed

23.

McCaul KD et al. What is the relationship between breast cancer risk and mammography screening? A meta-analytic review. Health Psychol. 1996;15(6):423–9.CrossRefPubMed

24.

Anton-Culver H et al. The cancer genetics network: recruitment results and pilot studies. Commun Genet. 2003;6(3):171–7.CrossRef

25.

Bowen DJ, Hay JL, Mayer J, Kuniyuki A, Meischke H, Harris J, et al. Predictors of recruited melanoma families into a behavioral intervention project. Contemp Clin Trials. 2012;33(1):85–92.PubMedCentralCrossRefPubMed

26.

Bowen DJ, Christensen CL, Powers D, Graves DR, Anderson CAM. Effects of counseling and ethnic identity on perceived risk and cancer worry in African American women. J Clin Psychol Med Settings. 1998;5:365–80.CrossRef

27.

Bowen DJ, Burke W, McTiernan A, Powers D, Durfy S, Gralow J, et al. Participation in breast cancer risk counseling among women with a history of cancer. Cancer Epidemiol Biomarkers Prev. 1999;8:581–6. PMID: 1042819.PubMed

28.

Bowen DJ, Powers D, Greenlee H. Effects of breast cancer risk counseling for sexual minority women. Health Care Women Int. 2005;27:59–74.CrossRef

29.

Bowen DJ, Powers DM. Effects of a mail/telephone intervention on breast health behaviors. Health Educ Behav. 2010;37(4):479–89.CrossRefPubMed

30.

Cancer Melanoma. In: Disease Risk Index. Harvard School of Public Health. 2008. http://www.diseaseriskindex.harvard.edu/update/hccpquiz.pl?lang=english&func=home&quiz=melanoma. Accessed 8 May 2014.

31.

Weinstock M, Risica P, Martin R, Rakowski W, Dube C, Berwick M, et al. Melanoma early detection with thorough skin self-examination the ‘Check It Out’ randomized trial. Am J Prev Med. 2007. doi:10.1016/j.amepre.2007.02.024.PubMedCentralPubMed

32.

Oh SS, Mayer JA, Lewis EC, Slymen DJ, Sallis JF, Elder JP, et al. Validating outdoor workers’ self-report of sun protection. Prev Med. 2004;39(4):798–803.CrossRefPubMed

33.

Lerman C, Daly M, Masny A, Balshem A. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol. 1994;12(4):843–50.PubMed

34.

Meropol NJ, Daly MB, Vig HS, Manion FJ, Manne SL, Mazar C, et al. Delivery of internet-based cancer genetic counselling services to patients’ homes: a feasibility study. J Telemed Telecare. 2011. doi:10.1258/jtt.2010.100116.PubMedCentralPubMed

35.

Manne S, Jacobsen PB, Ming ME, Winkel W, Dessureault S, Lessin SR. Tailored versus generic interventions for skin cancer risk reduction for family members of melanoma patients. Health Psychol: Off J Div Health Psychol, Am Psychol Assoc. 2010. doi:10.1037/a0021387.

36.

Kovalyshyn I. The impact of physician screening on melanoma detection. Arch Dermatol. 2011. doi:10.1001/archdermatol.2011.181.PubMed

37.

Lowery JT, Horick N, Kinney AY, Finkelstein DM, Garrett K, Haile RW, et al. A randomized trial to increase colonoscopy screening in members of high-risk families in the colorectal cancer family registry and cancer genetics network. Cancer Epidemiol Biomark Prev. 2014. doi:10.1158/1055-9965.EPI-13-1085.

38.

Torres SM, Ramos M, Leverence R, Bowen D, Berwick M, Hay J. A pilot study of skin cancer risk reduction behaviors, cancer communications, and skin cancer beliefs in Hispanics in a Southwestern primary care practice. Californian Journal of Health Promotion. 12:1; 95–100.

Title: Effects of web-based intervention on risk reduction behaviors in melanoma survivors
Authors: Deborah J. Bowen
Wylie Burke
Jennifer L. Hay
Hendrika Meischke
Julie N Harris
Publication date: 01-06-2015
Publisher: Springer US
Published in: Journal of Cancer Survivorship / Issue 2/2015
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI: https://doi.org/10.1007/s11764-014-0412-0

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Implications for cancer survivors

Please log in to get access to this content

Other articles of this Issue 2/2015

Cancer survivors’ experiences of using survivorship care plans: a systematic review of qualitative studies

A systematic review and meta-analysis of social cognitive theory-based physical activity and/or nutrition behavior change interventions for cancer survivors

Dispositional mindfulness predicts attenuated waking salivary cortisol levels in cancer survivors: a latent growth curve analysis

An algorithm to identify the development of lymphedema after breast cancer treatment

Differences between nurse practitioner and physician care providers on rates of secondary cancer screening and discussion of lifestyle changes among breast cancer survivors

The complex health profile of long-term cancer survivors: prevalence and predictors of comorbid conditions

Keynote webinar | Spotlight on antibody–drug conjugates in cancer